Jianjun Zhang MD

PubMed

• PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021.
  Mehmet Altan, Dawen Sui, Cai Xu, George R Simon, Saliha T Sulihem
  Journal of Immunotherapy and Precision Oncology. 2025-05-01
• Predictive role of inflammatory markers for the efficacy of first-line immunotherapy plus chemotherapy in advanced gastric cancer.
  Chenming Zhong, Ying Yuan, Yue Jiang, Guanglei Qiao, Zhoufeng Deng
  Discover Oncology. 2025-04-26
• Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status.
  Sara Nofal, Edwin J Ostrin, Jianjun Zhang, Jia Wu, Paul Scheet
  International Journal of Cancer. 2025-04-18

Journal Articles

• Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer (NSCLC)  
  Xiuning Le, Jianjun Zhang, John V Heymach, Clinical Lung Cancer
• Profiles of Brain Metastases: Prioritization of Therapeutic Targets  
  Raymond Sawaya, Zoran Gatalica, Isabella C Glitza, John V Heymach, Michael E Salacz, Michael A Davies, Amy B Heimberger, Nuhad K Ibrahim, Jianjun Zhang, Sherise D Ferg..., International Journal of Cancer
• Landscape of EGFR -Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Post-Progression in EGFR-Mutant NSCLC  
  Stephen G Swisher, Vassiliki A Papadimitrakopoulou, John V Heymach, Jack A Roth, Jianjun Zhang, William N William, Bonnie S Glisson, Clinical Cancer Research

Lectures

• Association of detection of aflatoxin in plasma of Kenyan women with increased detection of oncogenic HPV. 
  2019 ASCO Annual Meeting - 6/1/2019